532488:BOM
Divi's Laboratories Ltd
₹9,220.00
arrow_upward
+1.99%(+180.05) 1D
Okt 16, 3:56:15 PM GMT+5:30 · INR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa 532488...
Buksan
₹9,013.35
Mataas
₹9,247.50
Mababa
₹8,985.00
Mkt. cap
2.45T
Avg. na dami
33.69K
Dami
17.22K
Dividend
0.33%
Bawat tatlong buwang dividend
₹7.50
Petsa ng ex-dividend
Hul 24, 2026
P/E ratio
83.67
Mataas nang 52-wk
₹10,000.00
Mababa nang 52-wk
₹5,648.00
EPS
₹110.20
Mga natitirang share
265.47M
Bilang ng mga empleyado
12K
Buksan
₹9,013.35
Mataas
₹9,247.50
Mababa
₹8,985.00
Mkt. cap
2.45T
Avg. na dami
33.69K
Dami
17.22K
Dividend
0.33%
Bawat tatlong buwang dividend
₹7.50
Petsa ng ex-dividend
Hul 24, 2026
P/E ratio
83.67
Mataas nang 52-wk
₹10,000.00
Mababa nang 52-wk
₹5,648.00
EPS
₹110.20
Mga natitirang share
265.47M
Bilang ng mga empleyado
12K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
MarketWatch
·
9 oras ang nakalipas
These surprising stocks could be some of the biggest drivers of S&P 500 earnings growth
Bloomberg.com
·
1 oras ang nakalipas
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
24/7 Wall St.
·
5 araw ang nakalipas
These 3 International Dividend ETFs Outyield SCHD and Are Beating the S&P 500 Over the Past Year
FXStreet
·
3 araw ang nakalipas
Dow Jones futures gains ahead of US PPI, Retail Sales data
Profile
Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients and intermediates, headquartered in Hyderabad. The company manufactures and custom synthesizes generic APIs, intermediates. The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization. Wikipedia
Tungkol sa Divi's Laboratories Ltd